American Society of Clinical Oncology (ASCO) 2020 Jun 1 Jun 1, 2020 Supporting Materials Trial in Progress - Phase 1-2 for REGN5093 (METxMET) in MET-Altered Advanced NSCLC 1.1 MB Trial in Progress - Phase 1-2 for REGN5678 (PSMAxCD28) in mCRPC 1.3 MB Trial in Progress - Phase 3 for Libtayo in Adjuvant CSCC 218.1 KB Phase 2 of Libtayo in Advanced CSCC - Post Hoc Exploratory Analysis 142.7 KB Phase 2 of Libtayo in Advanced CSCC - Three-year follow-up 132 KB